Skye Bioscience Inc.’s Post

Dear colleagues, please visit our recently published case report https://lnkd.in/e8ReC6pi in the Journal of Clinical Case Reports by Wiley. 🔻 This study suggests nocturnal seizure-like movements as an unusual, though challenging, presentation of obstructive sleep apnea (OSA). 🔻A detailed history (daytime sleepiness, nonrestorative sleep, snoring, witnessed apnea, insomnia, family history of snoring or OSA, history of systemic hypertension or cardiovascular diseases, etc.) and physical examination (obesity, craniofacial and upper airway abnormalities, large neck circumference, and narrow airway) could help differentiate between OSA and nocturnal seizures. 🔻Subsequently, Video EEG and PSG can determine the diagnosis.

Dear colleagues, please visit our recently published case report https://lnkd.in/e8ReC6pi in the Journal of Clinical Case Reports by Wiley. 🔻 This study suggests nocturnal seizure-like movements as an unusual, though challenging, presentation of obstructive sleep apnea (OSA). 🔻A detailed history (daytime sleepiness, nonrestorative sleep, snoring, witnessed apnea, insomnia, family history of snoring or OSA, history of systemic hypertension or cardiovascular diseases, etc.) and physical examination (obesity, craniofacial and upper airway abnormalities, large neck circumference, and narrow airway) could help differentiate between OSA and nocturnal seizures. 🔻Subsequently, Video EEG and PSG can determine the diagnosis.

Do GLP-1s improve more than just weight loss? You’d be surprised. Tune in to our on-demand webinar, “Clinical Conversation: Broader Impact of GLP-1s,” where experts Dr. Donna Ryan and Tim Church, MD, MPH, PhD dive into the latest research, including the potential of GLP-1s to improve sleep apnea – a disorder that affects 39 million people in the US. Learn how these findings are shaping the future of treatment for common chronic conditions like sleep disorders, cardiovascular disease, and more. Visit here to watch the full on-demand clinical conversation: https://lnkd.in/gFueuK-N 

“Managing Obstructive Sleep Apnea (OSA):” A study with Kathleen R. Billings, MD, and John Maddalozzo, MD. 🛌 Conventional therapies like CPAP and oral appliances remain key for OSA symptom relief and overall health impact reduction. 🌿 Integrative medicine harmonizes conventional and complementary approaches. As obesity rates climb, weight loss and lifestyle programs emerge as promising integrative strategies alongside standard OSA treatments. 🔍 Complementary approaches may contribute to lowering the apnea-hypopnea index. #SleepHealth #OSA https://lnkd.in/gQS8xjsF

Understanding the Link: Sleep Patterns & Cancer Risk Dr. Kuldeep Sharma, Director of Radiation Oncology at Venkateshwar Hospital, highlights the vital role that sleep hygiene plays in managing stress and lowering cancer risk. He also recommends that adults should aim for at least 7 hours of quality sleep each night to promote and maintain overall health. #VenkateshwarHospital #CancerPrevention #HealthySleep #CancerAwareness #StressManagement 

Cardiovascular diseases are the leading cause of death globally, taking an estimated 17.9 million lives each year, according to the World Health Organization. A major step to easing this burden on healthcare systems globally is diagnosing and treating patients for obstructive sleep apnea, a sleep disorder which substantially increases the risk of cardiovascular disease. Learn about how the Nox T3s home sleep test can help: https://lnkd.in/gyBp3-kS #Cardiology #SleepApnea #SleepHealth #HeartHealth #HeartDiseaseAwareness Nox Health American Academy of Sleep Medicine

Here's our Chief Medical Officer giving clear insights on weight-loss drugs and CPAP therapy, highlighting the benefits of combining these treatments for those with obesity-related sleep apnea.

Where stigma dehumanizes people, medicine centers them. Pop culture and media attention present #chronic #conditions and the people who live with them as homogeneous. Depression, obesity, sleep apnea, HIV, Crohn's, and on and on... #stigma becomes one with the condition. Treatments are whispered about, hidden, pitied or shamed or avoided entirely. But medicine tells people that treatment of their condition - and, critically, their experience living with that condition - is worth close inspection. Clinical research is there, cheering loudly from behind the bench or within a protocol or in a new medical device: this condition is real! It is worth looking at head-on! It is worth time and investment and attention. It is worth improving. You are not alone. You are not this disease. It is exciting to watch medicine change. It is exciting to have multiple treatment options where once there was only stigma. Where once there was only shame. Responsible medicine almost never says "Here is your one solution." Instead, it says, "Let's see what will work for YOU." Where stigma dehumanizes people, medicine centers them.

Discuss #SyntheticBiology approaches to address heart, lung, blood, and sleep disorders at a virtual workshop Nov 4-5, 2024. Register by 5 p.m. ET Oct 28. https://bit.ly/3XRTPlR #SynBio #Bioengineering #HealthTechnology

Our findings from this large 12-year prospective study, published in Movement Disorders, involving over half a million participants suggest that vigorous physical exercise, limited sitting time, and high sleep quality are associated with a reduced risk of Parkinson's disease (PD). These results align with previous research and suggest that interventions such as exercise, reduced sedentary behavior, and healthy sleep habits, along with moderate coffee intake and vitamin D supplementation, could be effective in PD prevention. Further randomized clinical trials are needed to investigate the potential roles of various interventions in both primary and secondary PD prevention strategies. https://lnkd.in/gGVbvEmT